(Q38458572)

3 September 2017

title

Reappearance of HIV multidrug-resistance in plasma and circulating lymphocytes after reintroduction of antiretroviral therapy (English)

1 reference

3 September 2017

main subject

anti-retroviral agent

0 references

multiple drug resistance

1 reference

Dirk Albrecht

1

1 reference

3 September 2017

Bernhard Zöllner

2

1 reference

3 September 2017

Heinz-Hubert Feucht

3

1 reference

3 September 2017

Thore Lorenzen

4

1 reference

3 September 2017

Rainer Laufs

5

1 reference

3 September 2017

Albrecht Stoehr

6

1 reference

3 September 2017

Andreas Plettenberg

7

1 reference

3 September 2017

publication date

1 February 2002

1 reference

Journal of Clinical Virology

3 September 2017

published in

1 reference

3 September 2017

volume

24

1 reference

3 September 2017

issue

1-2

1 reference

3 September 2017

page(s)

93-98

1 reference

Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900231-1

7 January 2021

Confidence Limits on Phylogenies: an Approach using the Bootstrap

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900231-1

7 January 2021

Changes in human immunodeficiency virus type 1 populations after treatment interruption in patients failing antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900231-1

7 January 2021

Human immunodeficiency virus proviral DNA from peripheral blood and lymph nodes demonstrates concordant resistance mutations to zidovudine (codon 215) and didanosine (codon 74). Division of AIDS Treatment Research Initiative 003 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900231-1

7 January 2021

The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900231-1

7 January 2021

10.1016/S1386-6532(01)00231-1

Identifiers

DOI

1 reference

3 September 2017

1 reference